TIFFANY ROMANELLO: Open Payments
NPI 1689088940 · PEACHTREE CITY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,721 in 58 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $836 · 2025 $1,721
Food & beverage: $1,721
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $480 |
| ABBVIE INC. | 14 | $394 |
| PFIZER INC. | 3 | $168 |
| Regeneron Healthcare Solutions, Inc. | 3 | $114 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Amgen Inc. | 3 | $61 |
| Janssen Biotech, Inc. | 3 | $58 |
| Botanix SB Inc | 3 | $53 |
| LEO Pharma Inc. | 2 | $47 |
Products named: DUPIXENT, RINVOQ, LITFULO, SKYRIZI, Sotyktu, OTEZLA, TREMFYA, SOFDRA.
Industry payments across GA — which companies pay providers there.
